Antibody Breakthrough Targets Epstein-Barr Virus, Hinting at Transplant Protection
Researchers developed human antibodies against EBV surface proteins gp350 and gp42; in mice with humanized immune systems, one antibody protected against EBV infection, suggesting a new approach to prevent EBV-related diseases and transplant-related cancers, with safety testing and clinical trials planned.